MARKET

CVAC

CVAC

Curevac B.V.
NASDAQ
4.220
+0.090
+2.18%
Opening 11:09 12/18 EST
OPEN
4.150
PREV CLOSE
4.130
HIGH
4.238
LOW
4.090
VOLUME
565.49K
TURNOVER
--
52 WEEK HIGH
5.72
52 WEEK LOW
2.475
MARKET CAP
950.23M
P/E (TTM)
6.29
1D
5D
1M
3M
1Y
5Y
1D
BioNTech Closes Acquisition of CureVac
Reuters · 7h ago
CureVac Enters Oversold Territory (CVAC)
NASDAQ · 1d ago
Weekly Report: what happened at CVAC last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at CVAC last week (1201-1205)?
Weekly Report · 12/08 09:15
BioNTech Secures 81.7% of CureVac Shares in Tender Offer
Reuters · 12/03 14:01
Weekly Report: what happened at CVAC last week (1124-1128)?
Weekly Report · 12/01 09:14
CureVac Shareholders Approve BioNTech Exchange Offer
TipRanks · 11/26 15:27
BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3
Seeking Alpha · 11/26 12:49
More
About CVAC
CureVac NV, formerly CureVac AG, is a Germany-based clinical-stage biopharmaceutical company. The Company develops transformative medicines based on messenger ribonucleic acid, or mRNA. The Company's mRNAs are designed to prevent infections and to treat diseases by mimicking human biology to synthesize the desired proteins. Its technology platform optimizes mRNA constructs that encode functional proteins which either induce a desired immune response or replace defective or missing proteins using the cell’s intrinsic translation machinery. The Company's product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and molecular therapy. In prophylactic vaccines, the Company is advancing its second-generation mRNA backbone against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a range of infectious diseases, including seasonal influenza, in collaboration with GSK(Glaxo Smith Kline).

Webull offers CureVac BV stock information, including NASDAQ: CVAC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVAC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CVAC stock methods without spending real money on the virtual paper trading platform.